- Home
- CRVS vs UAMY Comparison
CRVS vs UAMY Comparison
Compare CRVS & UAMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVS
- UAMY
- Stock Information
- Founded
- CRVS 2014
- UAMY 1968
- Country
- CRVS United States
- UAMY United States
- Employees
- CRVS N/A
- UAMY N/A
- Industry
- CRVS Biotechnology: Pharmaceutical Preparations
- UAMY Metal Fabrications
- Sector
- CRVS Health Care
- UAMY Industrials
- Exchange
- CRVS Nasdaq
- UAMY Nasdaq
- Market Cap
- CRVS 305.4M
- UAMY 316.8M
- IPO Year
- CRVS 2016
- UAMY N/A
- Fundamental
- Price
- CRVS $5.75
- UAMY $4.54
- Analyst Decision
- CRVS Strong Buy
- UAMY Strong Buy
- Analyst Count
- CRVS 4
- UAMY 5
- Target Price
- CRVS $15.00
- UAMY $3.60
- AVG Volume (30 Days)
- CRVS 494.0K
- UAMY 6.3M
- Earning Date
- CRVS 08-07-2025
- UAMY 08-12-2025
- Dividend Yield
- CRVS N/A
- UAMY N/A
- EPS Growth
- CRVS N/A
- UAMY N/A
- EPS
- CRVS N/A
- UAMY N/A
- Revenue
- CRVS N/A
- UAMY $25,728,046.00
- Revenue This Year
- CRVS N/A
- UAMY $209.07
- Revenue Next Year
- CRVS N/A
- UAMY $98.95
- P/E Ratio
- CRVS N/A
- UAMY N/A
- Revenue Growth
- CRVS N/A
- UAMY 134.91
- 52 Week Low
- CRVS $2.54
- UAMY $0.49
- 52 Week High
- CRVS $10.00
- UAMY $5.13
- Technical
- Relative Strength Index (RSI)
- CRVS 65.10
- UAMY 64.05
- Support Level
- CRVS $5.28
- UAMY $4.38
- Resistance Level
- CRVS $5.64
- UAMY $5.13
- Average True Range (ATR)
- CRVS 0.30
- UAMY 0.40
- MACD
- CRVS 0.03
- UAMY 0.01
- Stochastic Oscillator
- CRVS 77.70
- UAMY 69.56
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).
About UAMY United States Antimony Corporation
United States Antimony Corp is a fully integrated mining, transportation, milling, smelting, and selling company. It has two operating segments: antimony and zeolite. Its products and services include antimony; silver; gold; zeolite products; and storage, handling, & packaging services. The company's geographical segments are the United States, Canada, and Mexico, of which the vast majority of its revenue comes from the United States.